Correlation Between 89bio and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both 89bio and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 89bio and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 89bio Inc and Travere Therapeutics, you can compare the effects of market volatilities on 89bio and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 89bio with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 89bio and Travere Therapeutics.
Diversification Opportunities for 89bio and Travere Therapeutics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between 89bio and Travere is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding 89bio Inc and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and 89bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 89bio Inc are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of 89bio i.e., 89bio and Travere Therapeutics go up and down completely randomly.
Pair Corralation between 89bio and Travere Therapeutics
Given the investment horizon of 90 days 89bio is expected to generate 1.4 times less return on investment than Travere Therapeutics. In addition to that, 89bio is 1.06 times more volatile than Travere Therapeutics. It trades about 0.09 of its total potential returns per unit of risk. Travere Therapeutics is currently generating about 0.14 per unit of volatility. If you would invest 1,456 in Travere Therapeutics on August 25, 2024 and sell it today you would earn a total of 369.00 from holding Travere Therapeutics or generate 25.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
89bio Inc vs. Travere Therapeutics
Performance |
| Timeline |
| 89bio Inc |
| Travere Therapeutics |
89bio and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 89bio and Travere Therapeutics
The main advantage of trading using opposite 89bio and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 89bio position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| 89bio vs. Eliem Therapeutics | 89bio vs. HCW Biologics | 89bio vs. Scpharmaceuticals | 89bio vs. Milestone Pharmaceuticals |
| Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. HCW Biologics | Travere Therapeutics vs. Scpharmaceuticals | Travere Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |